Solid cancers; standard population | Dose categories (Sv) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
VLD group: <0.005 Sv (very low); 2.5–10.0 km | LD group: 0.005–0.1 Sv (low); 1.4–2.5 km | HD group: ≥0.1 Sv (high); 1.1–1.4 km | Total | |||||||||
Oa | Eb | SMRc (95% CI) P d VLD: Baseline | Oa | Eb | SMRc (95% CI) P d SMR (LD)/SMR (VLD) | Oa | Eb | SMRc (95% CI) P d SMR (HD)/SMR (VLD) | Oa | Eb | SMRc (95% CI) P d | |
Hiroshima | ||||||||||||
Males | 218 | 184.6 | 1.181 (1.035–1.343)* 1.0 | 250 | 208.6 | 1.198 (1.059–1.351)** 1.015 | 147 | 104.6 | 1.406 (1.196–1.642)*** 1.190 | 615 | 497.7 | 1.236 (1.142–1.335)*** |
Females | 228 | 220.3 | 1.035 (0.909–1.174) NS 1.0 | 269 | 244.9 | 1.099 (0.975–1.234) NS 1.061 | 226 | 137.5 | 1.644 (1.443–1.865)*** 1.588 | 723 | 602.6 | 1.200 (1.116–1.289)*** |
Okayama | ||||||||||||
Males | 218 | 169.8 | 1.284 (1.123–1.458)*** 1.0 | 250 | 192.6 | 1.298 (1.145–1.461)*** 1.011 | 147 | 96.2 | 1.528 (1.303–1.788)*** 1.190 | 615 | 458.6 | 1.341 (1.238–1.448)*** |
Females | 228 | 211.5 | 1.078 (0.949–1.225) NS 1.0 | 269 | 234.8 | 1.146 (1.016–1.285)* 1.063 | 226 | 131.8 | 1.714 (1.503–1.942)*** 1.591 | 723 | 578.1 | 1.251 (1.163–1.344)*** |